Bank of Montreal
HARP

Bank of Montreal’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Bank of Montreal’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41
Closed -$9K – 5219
2021
Q1 		$9K Sell
41
-127
-76% -$25.5K ﹤0.01% 4431
2020
Q4 		$36K Buy
168
+119
+243% +$18.4K ﹤0.01% 4120
2020
Q3 		$8K Sell
49
-37
-43% -$5.34K ﹤0.01% 4253
2020
Q2 		$14K Buy
+86
New +$13.4K ﹤0.01% 4024
2020
Q1 		– Sell
-92
Closed -$14K – 4879
2019
Q4 		$14K Buy
92
+28
+44% +$4.25K ﹤0.01% 4479
2019
Q3 		$9K Buy
64
+14
+28% +$1.97K ﹤0.01% 4460
2019
Q2 		$6K Buy
+50
New +$5.81K ﹤0.01% 4659

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bank of Montreal's HARP Position: Q2 2021 in Review

Bank of Montreal sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2021, closing a stake of 41 shares — an estimated $9K sold.

Bank of Montreal first reported a position in HARP in Q2 2019 and held it in 7 quarters. The position peaked at $36K in Q4 2020. 85 funds tracked by Wall St. Rank hold HARP as of Q2 2021.

  • Bank of Montreal reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 41 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $9K.
  • Bank of Montreal first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Bank of Montreal's Harpoon Therapeutics, Inc. Common Stock position peaked at $36K in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.